| Abstrakt: |
A recent study conducted at Sultan Qaboos University Hospital in Muscat, Oman, explored the efficacy of clopidogrel therapy in managing nonischemic central retinal vein occlusion (CRVO). The study focused on a 54-year-old male patient with multiple systemic comorbidities who experienced significant improvement in visual acuity and retinal pathology after transitioning from aspirin to clopidogrel therapy. The researchers highlighted the potential superiority of clopidogrel over aspirin in select patients with CRVO and emphasized the need for further comparative studies to optimize treatment strategies. For more information, the full article can be accessed through the Oman Journal of Ophthalmology. [Extracted from the article] |
